- 80.9% of patients have epigastric pain symptom reduction - 17.9% of patients have side effects of the treatment regimen. The rates of bitter mouth and nausea were 12.3%, insomnia headache was 1.9%, urticaria 0.6%, diarrhea 3.1%.